Voloridge Investment Management, LLC Allogene Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$2.28 - $3.5 $580,725 - $891,464	-254,704 Reduced 63.59%	145,841 $468,000
Q3 2023 Nov 14, 2023	SELL	$3.17 - $5.96 $347,143 - $652,673	-109,509 Reduced 21.47%	400,545 $1.27 Million
Q2 2023 Aug 14, 2023	SELL	$4.53 - $6.74 $2.14 Million - $3.18 Million	-471,614 Reduced 48.04%	510,054 $2.53 Million
Q1 2023 May 15, 2023	SELL	$4.92 - $8.21 $308,301 - $514,463	-62,663 Reduced 6.0%	981,668 $4.85 Million
Q4 2022 Feb 14, 2023	BUY	$5.62 - $11.11 $1.43 Million - $2.83 Million	255,058 Added 32.32%	1,044,331 $6.57 Million
Q3 2022 Nov 14, 2022	SELL	$10.32 - $17.28 $563,348 - $943,280	-54,588 Reduced 6.47%	789,273 $8.52 Million
Q2 2022 Aug 15, 2022	BUY	$6.78 - $12.28 $341,481 - $618,494	50,366 Added 6.35%	843,861 $9.62 Million
Q1 2022 May 16, 2022	BUY	$7.65 - $15.29 $3.92 Million - $7.83 Million	512,109 Added 182.0%	793,495 $7.23 Million
Q4 2021 Feb 14, 2022	BUY	$13.13 - $24.52 $3.69 Million - $6.9 Million	281,386 New	281,386 $4.2 Million
Q1 2021 May 17, 2021	SELL	$25.79 - $39.02 $1.32 Million - $1.99 Million	-51,091 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$25.24 - $43.45 $1.65 Million - $2.84 Million	-65,254 Reduced 56.09%	51,091 $1.29 Million
Q3 2020 Nov 16, 2020	SELL	$32.38 - $44.96 $2.65 Million - $3.68 Million	-81,876 Reduced 41.31%	116,345 $4.39 Million
Q2 2020 Aug 14, 2020	BUY	$18.39 - $54.04 $3.65 Million - $10.7 Million	198,221 New	198,221 $8.49 Million

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.